HPE
10
-6
EA
68
6
SE
50
-2
XOM
48
-3
PWR
72
-2
LRCX
50
-3
USB
39
2
LOW
53
-2
BXP
42
-5
AVGO
37
-5
DOW
46
2
SBUX
27
-17
URI
58
-4
MSI
52
2
VLO
26
-2
COST
60
-3
APH
68
-2
OKE
56
-3
KIM
48
-6
MOS
25
-5
HPE
10
-6
EA
68
6
SE
50
-2
XOM
48
-3
PWR
72
-2
LRCX
50
-3
USB
39
2
LOW
53
-2
BXP
42
-5
AVGO
37
-5
DOW
46
2
SBUX
27
-17
URI
58
-4
MSI
52
2
VLO
26
-2
COST
60
-3
APH
68
-2
OKE
56
-3
KIM
48
-6
MOS
25
-5
Financhill
Back

ANI Pharmaceuticals Quote, Financials, Valuation and Earnings

Master the Market: The Formula for a 96.3% Win Rate Revealed!

Act now!
Buy
56

ANIP
ANI Pharmaceuticals

Last Price:
67.12
Seasonality Move:
1.89%

7 Day Trial

ALL ACCESS PASS

$ 7

He cracked the code to crypto

Now he says a new two-year bull market has begun. And he likes one altcoin above all others.

ANI Pharmaceuticals Price Quote

$67.12
+0.69 (+1.04%)
(Updated: May 2, 2024 at 6:15 PM ET)

ANI Pharmaceuticals Key Stats

Buy
56
ANI Pharmaceuticals (ANIP) is a Buy
Day range:
$65.68 - $67.30
52-week range:
$37.64 - $70.81
Dividend yield:
0%
P/E ratio:
78.15
P/S ratio:
2.48
P/B ratio:
3.23%
Volume:
109.9K
Avg. volume:
135K
1-year change:
74.27%
Market cap:
$1.4B
Revenue:
$486.8M
EPS:
$0.82

How Much Does ANI Pharmaceuticals Make?

Is ANI Pharmaceuticals Growing As A Company?

  • What Is ANI Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.4%
  • What Is ANI Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

ANI Pharmaceuticals Stock Price Performance

What Is ANI Pharmaceuticals 52-Week High & Low?

ANI Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy ANI Pharmaceuticals?

Is ANI Pharmaceuticals Cash Flow Positive?

  • What Is ANIP Cash Flow From Operations?
    Cash flow from operations (TTM) is $119M
  • What Is ANI Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $67.4M
  • What Is ANI Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$18.5M

ANI Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    ANIP return on invested capital is 2.72%
  • What Is ANI Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 2.25%
  • What Is ANIP Return On Equity?
    ROE is a measure of profitability and is 4.64%

ANI Pharmaceuticals Earnings Date & Stock Price

ANI Pharmaceuticals Competitors

  • Who Are ANI Pharmaceuticals's Competitors?
    Below is a list of companies who compete with ANI Pharmaceuticals or are related in some way:
    • ADMA Biologics Inc (ADMA)
    • Allogene Therapeutics Inc (ALLO)
    • Ligand Pharmaceuticals Inc (LGND)
    • Vanda Pharmaceuticals Inc (VNDA)
    • Dentsply Sirona Inc (XRAY)

ANI Pharmaceuticals Dividend Yield

Data Unavailable

ANI Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 16.96%
Revenue: 39.71% 5.38%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 79.80
Upside from Last Price: 20.13%

Major Shareholders

  • How many ANIP shares are owned by institutional investors?
    20.5M ANIP shares are owned by institutional investors
  • How many ANIP shares are owned by insiders?
    2.7M ANIP shares are owned by insiders